Evaluation of the parenchymal distribution of renal steatosis in chronic kidney disease using chemical shift magnetic resonance imaging
Advances in Clinical and Experimental Medicine · 21.06.2023 · 33 (5) · 455-462
DOI: 10.17219/acem/166512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, online erschienen am 21.06.2023. Verfasst von Hüseyin Aydın und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Magnetic Resonance Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: Renal steatosis is an abnormal accumulation of fat in the kidney and may cause chronic kidney disease (CKD) or CKD progression. OBJECTIVES: This pilot study aimed to evaluate the quantitative measurability of the parenchymal distribution of lipid deposition in the renal cortex and medulla using chemical shift magnetic resonance imaging (MRI) and investigate its relationship with clinical stages in CKD patients. MATERIAL AND METHODS: The study groups included CKD patients with diabetes (CKD-d) (n = 42), CKD patients without diabetes (CKD-nd) (n = 31) and control subjects (n = 15), all of whom underwent a 1.5T MRI of the abdomen using the Dixon two-point method. The fat fraction (FF) values in the renal cortex and medulla were calculated from measurements made on Dixon sequences, and then compared between the groups. RESULTS: The cortical FF value was higher than the medullary FF value in control (0.057 (0.053-0.064) compared to 0.045 (0.039-0.052)), CKD-nd (0.066 (0.059-0.071) compared to 0.063 (0.054-0.071)), and CKD-d (0.081 (0.071-0.091) compared to 0.069 (0.061-0.077)) groups (all p < 0.001). The CKD-d group cortical FF values were higher than those of the CKD-nd group (p < 0.001). The FF values began increasing at CKD stages 2 and 3, and reached statistical significance at stages 4 and 5 in CKD patients (p < 0.001). CONCLUSIONS: Renal parenchymal lipid deposition can be quantified separately in the cortex and medulla using chemical shift MRI. Fat accumulation occurred in cortical and medullary parenchyma in CKD patients, though predominantly in the cortex. This accumulation increased proportionally with the disease stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Radiology, Ankara Oncology Training and Research Hospital, University of Health Sciences, Turkey.
- Department of Biostatistics, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
- Department of Nephrology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Zitieren
APA
Aydın, H., Aydın, H., Karaibrahimoğlu, A., & Afsar, B. (2023). Evaluation of the parenchymal distribution of renal steatosis in chronic kidney disease using chemical shift magnetic resonance imaging. Advances in Clinical and Experimental Medicine, 33(5), 455-462. https://doi.org/10.17219/acem/166512
Vancouver
Aydın H, Aydın H, Karaibrahimoğlu A, Afsar B. Evaluation of the parenchymal distribution of renal steatosis in chronic kidney disease using chemical shift magnetic resonance imaging. Advances in Clinical and Experimental Medicine. 2023;33(5):455-462. doi:10.17219/acem/166512
BibTeX
@article{Aydn2023,
author = {Aydın, Hüseyin and Aydın, Hasan and Karaibrahimoğlu, Adnan and Afsar, Baris},
title = {Evaluation of the parenchymal distribution of renal steatosis in chronic kidney disease using chemical shift magnetic resonance imaging},
journal = {Advances in Clinical and Experimental Medicine},
year = {2023},
volume = {33},
number = {5},
pages = {455--462},
doi = {10.17219/acem/166512}
}
EUVIMED